Symbol       Canada   US  

Company Profile



Bellerophon Therapeutics, Inc.
Symbol: NASDAQ : BLPH
Email:
Website: www.bellerophon.com
Bellerophon Therapeutics, Inc. is a clinical-stage biotherapeutics company focused on developing innovative therapies at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary and cardiac diseases. Two of the company's product candidates are based on its proprietary pulsatile nitric oxide delivery device, INOpulse, one for the treatment of pulmonary arterial hypertension and a second for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease. Bellerophon's other program is bioabsorbable cardiac matrix, or BCM, which is being developed for the prevention of cardiac remodeling and subsequent chronic heart failure following acute myocardial infarction, commonly known as a heart attack.
 
BLPH Discussion Forums
Seeking Alpha
Silicon Investor
StockHouse
Yahoo

Live Discussion of BLPH


Search by Symbol       Canada   US  


Top